The present invention provides TrkB agonist antibodies or antigen-binding fragment specifically improves TrkB activities. Present invention provides using the treatment method of antibody to survive and regenerate retinal ganglial cells for promoting, make and treat or prevent subject to suffer from or the various neurodegeneration coxiditions such as glaucomas of the exploitation of risky trouble.